title: [Pharma-clinics. How I treat ... hypo- or hyperkalemia].
abstract: The treatment of dyskalemia must be primarily etiological and later symptomatic. When moderate but significant hypokaliemia exists (K < 3 mmol/l or 3.5 mmol/l with cardiac disease), oral K supplements must be/given. The intravenous route must be reserved for emergency or impossible oral administration. Acute and severe hyperkalemia (K > 7 mmol/l) must be first corrected by different intravenous measures with secondary oral intervention. In chronic and/or moderate hyperkaliemia (K > 5.5 mmol/l), the oral route for treatment is preferred. In any case, the research of the cause (mainly drug induced) is fundamental.
authors.affiliation: Service Médecine Interne, CHU Ourthe-Amblève.
authors.forename: I
authors.initials: I
authors.lastname: Neven
authors.forename: J M
authors.initials: JM
authors.lastname: Krzesinski
mesh_terms: D005440:Fluid Therapy; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology / Q000628:therapy*; D007008:Hypokalemia / Q000209:etiology / Q000628:therapy*; D011188:Potassium / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D011188:Potassium